+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
ID05870969

Study of a Digital Liver Cancer Risk Management Program to Improve Early Diagnosis in Chinese Adults Aged 18 to 75

Led by Ruijin Hospital · Updated on 2023-05-23

20000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a liver cancer risk stratification management approach to see if it improves early diagnosis rates of liver cancer in high-risk populations in China. The study focuses on patients with conditions such as chronic hepatitis B and C, cirrhosis, and metabolic dysfunction-associated fatty liver disease. This observational real-world study is conducted by Ruijin Hospital and aims to follow participants for up to three years to monitor liver cancer occurrence and early diagnosis effectiveness. Participants are grouped based on liver cancer risk levels according to local guidelines very high, high, medium, and low risk. They will undergo liver cancer surveillance at intervals of every 3 months, every 6 months, or annually. Surveillance includes tests such as serum AFP and ultrasound exams to monitor liver health. This management aims to standardize follow-up procedures and improve detection timing. During the study, participants will have regular follow-ups for liver cancer surveillance and risk stratification assessments. Researchers will collect data on early diagnosis rates, the distribution of risk levels at screening and follow-up, and the cumulative incidence of liver cancer over three years. The trial will monitor participants for up to four years collectively, including initial screening and long-term follow-up. Safety and compliance will be tracked throughout the study period.

CONDITIONS

Brief Title

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Research Team

Q

Qing Xie, MD

H

Honglian Gui, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here